Bd expands capacity for advanced prefillable syringes and enhances injection experience for the next generation of biologics

Le pont-de-claix, france , sept. 18, 2024 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, announced the commercial release of the bd neopak™ xtraflow™ glass prefillable syringe and the latest capacity expansion of the bd neopak™ glass prefillable syringe platform to serve the growing market for biologic therapies.
BDX Ratings Summary
BDX Quant Ranking